Opus Genetics
IRD
38 hedge funds and large institutions have $5.65M invested in Opus Genetics in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
23% more funds holding
Funds holding: 31 → 38 (+7)
1% less capital invested
Capital invested by funds: $5.71M → $5.65M (-$63.4K)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$191K |
| 2 |
Morgan Stanley
New York
|
+$181K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$167K |
| 4 |
Renaissance Technologies
New York
|
+$112K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$96.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$43.9K |
| 2 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$41.1K |
| 3 |
Goldman Sachs
New York
|
-$25.9K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$21.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Creative Planning
Overland Park,
Kansas
| $14K | – | – | – |
|
|
MC
27
Moors & Cabot
Boston,
Massachusetts
| $12K | -$4.83K | -14 | -27% |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| $12K | – | – | – |
|
|
FA
29
FCG Advisors
Chatham,
New Jersey
| $11K | – | – | – |
|
|
30
Citadel Advisors
Miami,
Florida
| $10K | -$12.1K | -35 | -53% |
|
31
Canada Life
Winnipeg,
Manitoba, Canada
| $6K | – | – | – |
|
32
Citigroup
New York
| $5K | – | – | – |
|
|
WA
33
WFG Advisors
Dallas,
Texas
| $5K | +$5.18K | +15 | New |
|
|
NPC
34
National Planning Corporation
El Segundo,
California
| $1.6K | +$1.38K | +4 | New |
|
|
TRCT
35
Tower Research Capital (TRC)
New York
| $1K | -$1.73K | -5 | -63% |
|
|
CP
36
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
38
Ameriprise
Minneapolis,
Minnesota
| – | -$1K | -3 | Closed |
|
|
HF
39
Hoxton Financial
Shepherdstown,
West Virginia
| – | +$345 | +1 | New |
|
IRD Hedge Fund Activity: Q4 2014 in Review
38 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2014, worth a combined $5.65M — down 1.1% from $5.71M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IRD positions and 1 closed out — a net gain of 7 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Virtu KCG Holdings, adding an estimated $191K. The largest seller was Deutsche Bank, cutting an estimated $43.9K.
- 38 institutional investors held Opus Genetics (IRD) as of Q4 2014, up from 31 in Q3 2014.
- Funds reported $5.65M of Opus Genetics stock for Q4 2014, down 1.1% quarter-over-quarter.
- 8 funds opened new Opus Genetics positions in Q4 2014 and 1 closed out, a net change of +7 holders.
- The largest Opus Genetics buyer in Q4 2014 was Virtu KCG Holdings, an estimated $191K added.
- The largest Opus Genetics seller in Q4 2014 was Deutsche Bank, an estimated $43.9K sold.
Based on aggregated 13F filings for Q4 2014.